A carregar...

Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival

BACKGROUND: We sought to develop and validate clinically relevant, early assessment continuous tumor measurement–based metrics for predicting overall survival (OS) using the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 data warehouse. METHODS: Data from 13 trials representing 2096 patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: An, Ming-Wen, Dong, Xinxin, Meyers, Jeffrey, Han, Yu, Grothey, Axel, Bogaerts, Jan, Sargent, Daniel J., Mandrekar, Sumithra J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4643633/
https://ncbi.nlm.nih.gov/pubmed/26296640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv239
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!